AIMLogo.jpg
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
July 03, 2024 08:55 ET | AIM ImmunoTech Inc.
OCALA, Fla., July 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the next CEO Corner segment has been published on the Company’s...
Cross Keys Capital Advises New Jersey Cancer Care, PA, in Its Partnership with Regional Cancer Care Associates
July 02, 2024 08:00 ET | Cross Keys Capital, LLC.
Fort Lauderdale, July 02, 2024 (GLOBE NEWSWIRE) -- Cross Keys Capital, LLC, a leading independent investment banking firm providing M&A advisory services to physician group practices and...
sphericalinsightsoptionblue.png
Global Cancer Diagnostics Market Size To Exceed USD 323.17 Billion By 2033 | CAGR of 8.71%
July 01, 2024 20:00 ET | SPHERICAL INSIGHTS LLP
New York, United States , July 01, 2024 (GLOBE NEWSWIRE) -- The Global Cancer Diagnostics Market Size is to Grow from USD 140.25 Billion in 2023 to USD 323.17 Billion by 2033, at a CAGR of 8.71%...
JJ_Logo_SingleLine_Red_RGB.png
Nipocalimab pivotal Phase 3 trial demonstrates sustained disease control in FcRn class for a broad population of myasthenia gravis patients
June 28, 2024 12:09 ET | Janssen Cilag International NV
First FcRn blocker to demonstrate superiority in Myasthenia Gravis - Activities of Daily Living score (MG-ADL) a over placebo when added to standard of care over 24 weeks in antibody positive...
Lantheus_Logo.png
Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers
June 27, 2024 07:05 ET | Lantheus Holdings, Inc.
BEDFORD, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight...
Save the date: Die neue Ära der Krebsbehandlung wird präsentiert auf dem ICPO Theranostics Virtual Summit, 14. - 15. November 2024
June 27, 2024 00:00 ET | ICPO Foundation
Die neue Ära der Krebsbehandlung wird präsentiert auf dem ICPO Theranostics Virtual Summit, 14. - 15. November 2024 Die ICPO Foundation bietet ein erstklassiges wissenschaftliches Programm, das...
ICPO Theranostics Virtual Summit 2024
Save the date in your event calendar: Join and learn about the new era of cancer care at the ICPO Theranostics Virtual Summit, Nov 14 -15, 2024
June 27, 2024 00:00 ET | ICPO Foundation
Save the date in your event calendar: Join and learn about the new era of cancer care at the ICPO Theranostics Virtual Summit, Nov 14 -15, 2024 The ICPO Foundation offers a world-class scientific...
image (5).png
Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of healthcare AI
June 25, 2024 09:00 ET | Qure.ai Technologies Limited
Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of healthcare AI.
Logo_final_color.png
Industry Leader John Maraganore, Ph.D., Joins Cybrexa Therapeutics as Strategic Advisor
June 25, 2024 08:07 ET | Cybrexa Therapeutics
NEW HAVEN, Conn., June 25, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC)...
logo 600X600.png
Veterinary Oncology Market to Hit $1,563.7 Million by 2031, at a CAGR of 11.6%, says Coherent Market Insights
June 25, 2024 07:15 ET | CMI
Burlingame, June 25, 2024 (GLOBE NEWSWIRE) -- The global Veterinary Oncology Market size was valued at US$ 724.9 Million in 2024 and is expected to reach US$ 1,563.7 Million by 2031, growing at a...